Bayer Aktiengesellschaft (BAYRY)

USD 4.92

(-2.19%)

Total Debt Summary of Bayer Aktiengesellschaft

  • Bayer Aktiengesellschaft's latest annual total debt in 2023 was 44.78 Billion EUR , up 8.4% from previous year.
  • Bayer Aktiengesellschaft's latest quarterly total debt in 2024 Q2 was 46.57 Billion EUR , up 0.67% from previous quarter.
  • Bayer Aktiengesellschaft reported annual total debt of 41.32 Billion EUR in 2022, up 4.53% from previous year.
  • Bayer Aktiengesellschaft reported annual total debt of 39.53 Billion EUR in 2021, down -4.87% from previous year.
  • Bayer Aktiengesellschaft reported quarterly total debt of 46.57 Billion EUR for 2024 Q2, up 0.67% from previous quarter.
  • Bayer Aktiengesellschaft reported quarterly total debt of 44.78 Billion EUR for 2023 Q4, down -5.56% from previous quarter.

Annual Total Debt Chart of Bayer Aktiengesellschaft (2023 - 1998)

Historical Annual Total Debt of Bayer Aktiengesellschaft (2023 - 1998)

Year Total Debt Total Debt Growth
2023 44.78 Billion EUR 8.4%
2022 41.32 Billion EUR 4.53%
2021 39.53 Billion EUR -4.87%
2020 41.55 Billion EUR 6.87%
2019 38.88 Billion EUR -4.39%
2018 40.66 Billion EUR 207.89%
2017 13.2 Billion EUR -27.68%
2016 18.26 Billion EUR -2.85%
2015 18.8 Billion EUR -2.29%
2014 19.24 Billion EUR 167.07%
2013 7.2 Billion EUR -19.16%
2012 8.91 Billion EUR -18.4%
2011 10.92 Billion EUR -1.1%
2010 11.04 Billion EUR -8.76%
2009 12.1 Billion EUR -22.93%
2008 15.7 Billion EUR 13.77%
2007 13.8 Billion EUR -4.34%
2006 14.42 Billion EUR 105.9%
2005 7 Billion EUR -27.88%
2004 9.71 Billion EUR 3.25%
2003 9.4 Billion EUR -7.46%
2002 10.16 Billion EUR 37.54%
2001 7.39 Billion EUR 10.64%
2000 6.68 Billion EUR 49.63%
1999 4.46 Billion EUR -5.58%
1998 4.73 Billion EUR 0.0%

Peer Total Debt Comparison of Bayer Aktiengesellschaft

Name Total Debt Total Debt Difference
AstraZeneca PLC 28.58 Billion USD -56.706%
Bristol-Myers Squibb Company PFD CONV 2 41.46 Billion USD -8.019%
CSPC Pharmaceutical Group Limited 99.64 Million USD -44848.128%
Clarus Therapeutics Holdings, Inc. 42.26 Million USD -105861.816%
Novartis AG 26.34 Billion USD -69.99%
PT Kalbe Farma Tbk. 40.4 Million USD -110748.046%